Saponins

Saponins: A Comprehensive Reference

1. Identity, Nomenclature, and Chemical Classification

Saponins are a group of naturally occurring plant glycosides, characterized by their strong foam-forming properties in aqueous solution. The name derives from the Latin sapon, meaning "soap," reflecting this defining physical property. Saponins are a structurally diverse class of compounds occurring in many plant species, which are characterized by a skeleton derived from the 30-carbon precursor oxidosqualene to which glycosyl residues are attached.

Saponin isolated from medicinal plants is a naturally occurring bioorganic molecule with high molecular weight; its aglycone (water non-soluble part) nucleus has 27 to 30 carbon atoms, besides one or two sugar moieties (water soluble part) containing at least 6 or 12 carbon atoms, respectively. This dual hydrophobic/hydrophilic architecture gives saponins their characteristic amphiphilic, surfactant-like behavior.

Traditionally, they are subdivided into triterpenoid and steroid glycosides, or into triterpenoid, spirostanol, and furostanol saponins. A more granular classification identifies eleven major structural classes:

• In this way, 11 main classes of saponins were distinguished: dammaranes, tirucallanes, lupanes, hopanes, oleananes, taraxasteranes, ursanes, cycloartanes, lanostanes, cucurbitanes, and steroids.

Triterpenoid glycosides are the most widely distributed in the plant kingdom. These molecules are composed of isoprene units derived from the mevalonate pathway, building a pentacyclic compound with 30 carbon atoms. The steroid glycosides are derived triterpenoids with two main ring structures, including the structure of tetracyclic six-membered rings and bicyclic five-membered rings containing 27 carbon atoms.

Triterpenoids or triterpenoid saponins are pentacyclic molecules that are ultimately synthesized from isoprene. Steroidal saponins are tetracyclic molecules that are ultimately synthesized from acetyl coenzyme A (CoA). Steroidal saponin is mostly distributed among monocotyledon families such as Asparagaceae, Amaryllidaceae, Dioscoreaceae, Smilacaceae, and Liliaceae. Even though it is unusual, it could also be detected to some extent by dicotyledonous angiosperms, such as Plantaginaceae, Zygophyllaceae, Fabaceae, Asteraceae, and Solanaceae.

Structurally diverse saponins may be mono-, bi-, or tridesmosidic, linear or branched, by linking with the aglycone moiety (sapogenin) through an ether or ester bond. This structural diversity in saponins shows a huge range of hydrophobicity, acidity, and polarity, which defines their multiple pharmacological as well as biological actions.

The sugar moieties attached to saponin aglycones are varied. Glucose, galactose, glucuronic acid, rhamnose, xylose, and arabinose are the most abundant hexoses and pentoses in the saccharide chains. In more rare cases, fucose, quinovose, ribose and apiose may also be incorporated.

2. Natural Sources

Saponins are a class of natural phytochemicals which can be found in more than 500 plant species. They are usually extracted from many legumes, ginseng roots, licorice roots, spinach leaves, tea leaves and the bark of Quillaja saponaria Molina trees.

Generally, as a phytochemical, the content of saponins in plants is usually very low (about 1%), but the bark of Quillaja saponaria Molina tree contains up to 10% of saponins, which is also the main source of saponins (Quillaja saponins) for industrial applications.

Saponins are present in a wide range of plant species throughout the bark, leaves, stems, roots and flowers but particularly in soapwort (genus Saponaria), the soapbark tree (Quillaja saponaria), common corn-cockle (Agrostemma githago L.), baby's breath (Gypsophila spp.) and soybeans (Glycine max L.).

Several common sources of saponins include soybeans, which have approximately 5% saponin content by dry weight, soapwort plants (Saponaria), the root of which was used historically as soap, as well as alfalfa, aloe, asparagus, grapes, chickpeas, yucca, and various other beans and weeds.

Saponins are found mainly in plants but are also present in lower marine animals and some bacteria. Notable plant sources and their associated saponin classes include:

• Panax ginseng (Asian ginseng) and related species: ginsenosides (dammarane-type triterpenoids)
• Glycyrrhiza glabra (licorice): glycyrrhizin and related oleanane-type saponins. Glycyrrhizae Radix et Rhizoma is regarded as one of the most popular and commonly used herbal medicines and has been used in traditional Chinese medicine (TCM) prescriptions for over 2000 years.
• Quillaja saponaria (soapbark tree): Quillaja saponins / QS-21
• Dioscorea species (wild yam): steroidal saponins including diosgenin
• Medicago sativa (alfalfa): alfalfa saponins
• Gynostemma pentaphyllum: gypenosides
• Astragalus membranaceus: astragalosides

The plant source may be selected from shikakai, soybeans, beans, peas, lucerne, tea, spinach, sugar beet, quinoa, liquorice, sunflower, horse chestnut, ginseng, oats, capsicum peppers, aubergine, tomato seed, alliums, asparagus, yam, fenugreek, yucca and ginseng, mung beans, and others including Quillaja saponaria and Saponaria officinalis.

3. Common Preparations and Dosage Forms

Saponins are used in soaps, medicines (e.g., drug adjuvants), fire extinguishers, dietary supplements, steroid synthesis, and in carbonated beverages (for example, being responsible for maintaining the head on root beer).

In pharmaceutical and supplement contexts, saponins are prepared in multiple forms. Any part of the plant may be used for extracting the saponin material, including leaves, stems, roots, bulbs, blossom and fruit (including the skin, flesh and seed of the fruit). The saponin material is typically obtained by extraction from a plant source employing water, alcohol, or a water/alcohol solution. In some embodiments, the alcohol is ethanol or methanol.

Oral dosage forms include tablets, powders, granules, and liquid suspensions. In one pilot study, the effects of Astragalus and Panax saponins (APS) on whey protein absorption, intestinal permeability, and muscle function in healthy adults were investigated across different age groups via a randomized, double-blind, placebo-controlled crossover trial with 30 healthy participants. A randomized, double-blind, parallel-controlled clinical trial is being carried out evaluating the efficacy and safety of Escin (a horse chestnut saponin) as adjunctive treatment in patients, as either an oral formulation (40 mg three times a day) or injection (20 mg intravenously once a day) for 12 days.

4. Traditional and Historical Use

The use of saponin-containing plants predates any knowledge of their chemical constitution by thousands of years, embedded deeply in ethnobotanical traditions across multiple continents.

4.1 Cleansing and Fishing

Soapbark, soapwort, soapberry and quinoa are common crops rich in saponins, where their names are tied with the surface-reduction capability that made them traditionally applied as soap. Since prehistoric times, cultures throughout the world have used fish-killing plants, typically containing saponins, for fishing. The ichthyotoxic (fish-stunning) activity of saponin-rich plants was exploited across indigenous cultures in South America, Africa, and Asia long before the active compounds were isolated.

4.2 Traditional Chinese Medicine (TCM)

Legendary Emperor Shennong classified hundreds of medicinal and poisonous herbs in Shennong's Herbal Classic (The Classic of Herbal Medicine), the oldest pharmacopoeia in the world. Ever since, humankind has been using a variety of plants as nutrients, beverages, cosmetics, dyes, and medicines to maintain health status and improve quality of life.

Traditional Chinese medicines (TCMs) are currently attracting attention worldwide as alternative and supplemental medicines, with ginseng, as the "King of all herbs," receiving particular attention. Especially in East Asia, ginseng is deemed to be one of the most precious plants in herbal medicine.

Glycyrrhizae Radix et Rhizoma is regarded as one of the most popular and commonly used herbal medicines and has been used in traditional Chinese medicine (TCM) prescriptions for over 2000 years. Glycyrrhizin — the principal saponin of licorice root — was used in decoctions for respiratory ailments, digestive complaints, and as a harmonizing agent in multi-herb formulas.

Traditional Chinese herbal medicine (TCM), an ancient science with unique anti-cancer advantages, has achieved outstanding results in long-term clinical practice. Saponins are widely found in CHM plants such as Panax ginseng, and exert a variety of important biological activities including antitumor, immunomodulatory, antioxidant, anti-inflammatory, hypoglycemic, and therapeutic effects in cardiovascular diseases.

4.3 Ayurveda and Indian Traditions

In traditional South Asian medicine, several saponin-bearing plants held recognized therapeutic roles. In India, methi (fenugreek) was used as a digestive aid, sometimes roasted or soaked to mellow its strong taste. Fenugreek contains steroidal saponins including diosgenin and protodioscin, which are now studied for their metabolic effects. From an Ayurvedic standpoint, classical texts like the Caraka Saṃhitā and Sushruta Saṃhitā do not mention "saponin" by name, yet many of the plants they prescribe — including ashwagandha (Withania somnifera) and tribulus (Tribulus terrestris) — are now known to contain pharmacologically active saponins.

4.4 Andean Cultures and Quinoa

In South America, Andean people soaked and rinsed quinoa for millennia, reducing bitterness and saponin levels while enjoying its protein-rich grain. This processing practice represents an implicit empirical knowledge of saponins as antinutritional factors at high concentrations — an understanding later confirmed by modern food science.

4.5 Historical View as Antinutritional

Saponins were historically regarded in some contexts as antinutritional factors and efforts were made to reduce their levels in specific products. In recent years, however, accumulating evidence has highlighted a broad spectrum of biological activities of saponins, including anti-inflammatory, antioxidant, and anticancer effects.

5. Key Constituents and Notable Individual Saponins

The term "saponins" is a collective designation encompassing hundreds of distinct compounds. Several are the focus of ongoing research:

• Ginsenosides (e.g., Rb1, Rg1, Re, Rg3, Rh2): Dammarane-type triterpenoid saponins from Panax ginseng and related species. Ginsenosides are saponins produced by Panax species which are known for their antioxidant, anti-inflammatory, and anti-cancer activities.
• Glycyrrhizin: The principal saponin of licorice, an oleanane-type triterpenoid. Pentacyclic triterpene saponins are common secondary metabolites in these plants, synthesized via the isoprenoid pathway to produce a hydrophobic triterpenoid aglycone containing a hydrophilic sugar chain.
• QS-21: A purified triterpene saponin from Quillaja saponaria. QS-21, a triterpenoid saponin from Quillaja saponaria, is the most extensively studied and has been incorporated into licensed vaccines such as Shingrix, Mosquirix, and Arexvy.
• Diosgenin / Dioscin: Steroidal sapogenins from Dioscorea species, widely studied for metabolic, anti-inflammatory, and anticancer properties. Diosgenin, a steroidal sapogenin, has the potential of preventing neurological diseases by affecting different signaling pathways, increasing bone formation, and increasing antithrombotic activity.
• Astragaloside IV: A lanostane-type saponin from Astragalus membranaceus, studied for cardioprotective and immunomodulatory effects.
• Escin (Aescin): A triterpenoid saponin complex from horse chestnut (Aesculus hippocastanum), with established use in chronic venous insufficiency.
• Saikosaponins: Oleanane-type triterpenoids from Bupleurum species, used in TCM for hepatoprotection and anti-inflammatory effects.
• Gypenosides: Gynostemma pentaphyllum saponins show anticancer, cardioprotective, hepatoprotective, neuroprotective, antidiabetic, antiobesity, and anti-inflammatory effects.

6. Mechanisms of Action

Saponins exert their biological effects through multiple, often overlapping mechanisms. Their amphiphilic structure is central to most of these actions.

6.1 Membrane Interaction and Permeabilization

Saponins comprise a class of plant natural products that incorporate a lipophilic terpenoid core to which one or more carbohydrate residues are appended. They are amphiphilic molecules and often exhibit toxic biological profiles, likely as a result of their roles as vital components in protective coatings to defend against phytopathogen infection and insect predation.

Some saponins readily increase the permeability of the small intestinal mucosal cells, thereby inhibiting active nutrient transport and facilitating the uptake of materials to which the gut would normally be impermeable.

6.2 Cholesterol Binding and Lipid Metabolism

Most saponins form insoluble complexes with 3-β-hydroxysteroids and are known to interact with bile acids and cholesterol, forming large mixed micelles. One possible mechanism of action is the ability of saponins to form insoluble complexes with cholesterol in the intestinal lumen. The main mechanism of the cholesterol-lowering effect is the displacement of cholesterol molecules from the bile salt micelles, leading to formation of cholesterol precipitates that cannot pass through the mucus layer of the intestine.

Saponin is proposed to lower serum cholesterol by increasing the conversion of cholesterol into bile acids through the upregulation of a rate-limiting enzyme, CYP7A1, in hepatic bile acid synthesis.

Saponins are thought to be involved in the regulation of lipid metabolism in the body; they suppress the appetite and thus reduce energy intake by modulating pro-opiomelanocortin/Cocaine amphetamine regulated transcript (POMC/CART) neurons and neuropeptide Y/agouti-related peptide (NPY/AGRP) neurons in the hypothalamus, the appetite control center.

Saponins directly activate the AMP-activated protein kinase (AMPK) signaling pathway and related transcriptional regulators such as peroxisome-proliferator-activated-receptors (PPAR), CCAAT/enhancer-binding proteins (C/EBP), and sterol-regulatory element binding proteins.

6.3 Immunomodulation

QS-21 strongly potentiates both cellular and humoral immune responses to purified antigens. It directly activates human monocyte-derived dendritic cells (moDCs) and promotes a pro-inflammatory transcriptional program. Cholesterol-dependent QS-21 endocytosis followed by lysosomal destabilization and Syk kinase activation were prerequisites for this response. Both QuilA and QS-21 activate the NLRP3 inflammasome in vitro. Furthermore, ISCOMATRIX, an adjuvant containing different QuilA fractions, also activates the inflammasome in vitro and in vivo.

6.4 Anticancer Mechanisms

Saponins demonstrate significant anticancer activity, such as anti-proliferation, anti-metastasis, anti-angiogenesis and reversal of multi-drug resistance (MDR) effects through mechanisms that include induction of apoptosis and promotion of cell differentiation. They had also been reported to reduce the side-effects of radiotherapy and chemotherapy.

Due to the great variability of their structures, saponins always display anti-tumorigenic effects through a variety of antitumor pathways.

6.5 Inhibition of Digestive Enzymes

Some studies have shown interesting inhibitory activities of saponins on digestive enzymes such as lipase, amylase, and glucosidase enzymes. Such bioactivities are of recent relevance because any limited digestion of dietary macronutrients such as lipids or carbohydrates is currently considered a relevant strategy against important chronic diseases such as obesity, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, or diabetes.

7. Scientific Evidence by Area of Use

It is essential to note that virtually all foundational work has used animal and in vitro models, and to date there are very few human data for many proposed applications of saponins. The sections below clearly delineate evidence strength.

7.1 Cardiovascular and Lipid-Lowering Effects

Proposed mechanism: Saponins have the capability to create non-soluble compounds with cholesterol as well as other sterols and bile acids. They possess the ability to trap total cholesterol, LDL, and bile salts in the intestines, inhibiting their absorption, while not affecting HDL levels.

Animal evidence: The abnormal serum lipid levels in hyperlipidemic rats were ameliorated by alfalfa saponin extract (ASE) administration. Both ASE prevention group and treatment group significantly reduced liver total cholesterol (TC) and increased liver total bile acids (TBA) level (P<0.05). These findings are from an animal model (40 male Sprague-Dawley rats) and do not directly translate to humans.

Limitations and human evidence: These functionalities are thought to result in the cholesterol-lowering capacities of saponins in some animal species; however, their hypocholesterolemic effects in humans are more speculative. Human clinical trials specifically isolating saponin effects on blood lipids remain limited and methodologically varied. Saponins, as biologically active substances present in plants, have lipid-lowering, inflammation-reducing, and anti-atherosclerotic effects — although the bulk of this evidence derives from preclinical or combined dietary intervention studies rather than isolated human saponin trials.

Glycyrrhizin and ginsenosides from edible herbs can be used as a health supplement in routine intake for cardiac protection. DT-13, dioscin, astragaloside IV, glycyrrhizin, ophiopogonin D, and trillin possess strong cardioprotective activity and need to be explored further in clinical applications. This conclusion from a 2018 PMC review underscores that the cardioprotective evidence remains largely preclinical.

7.2 Immunomodulation and Vaccine Adjuvancy

This is the most clinically substantiated area of saponin application. Saponins were initially shown to have an adjuvant effect in 1925, when research showed that they may dramatically increase antibody responses against tetanus and diphtheria. Since 1964, saponins isolated from the bark of the South American soapbark tree (Quillaja saponaria Molina) have been the main subject of studies on the effects of saponin adjuvants.

These amphiphatic plant glycosides possess a variety of pharmacological activities including immunoadjuvant, antitumor, anti-inflammatory, and antimicrobial properties, which have been extensively studied. The limitations of aluminum salts that are unable to elicit cell responses against intracellular pathogens such as those causing malaria, tuberculosis, or AIDS, have driven the development of new alternative adjuvants such as QS-21, a triterpene saponin purified from Quillaja saponaria.

QS-21 is a potent immunostimulant that promotes both humoral and cellular immunity and is a component of several FDA-approved adjuvant systems. Current understanding of the cellular and molecular mechanisms of QS-21 action includes interaction with antigen-presenting cells and role in inflammasome activation and T cell polarization.

More than 30 years ago, semi-purified extracts (Quil A) from the cortex of Quillaja saponaria were found to be highly effective as adjuvants in veterinary vaccines. However, due to significant and variable toxicity effects, Quil A was not deemed appropriate for human vaccines. More refined purification methods have led to multiple fractions derived from the original plant extract. QS-21, as a purified fraction, possesses strong adjuvant activity and limited toxicity when compared to the other fractions.

Evidence strength: Strong (for QS-21 specifically). QS-21 has been incorporated into approved human vaccines (including Shingrix for shingles, Mosquirix for malaria, and Arexvy for RSV), representing the most robust and clinically validated application of any saponin compound.

7.3 Anticancer Activity

The presence of saponins has been reported in more than 100 families of plants, out of which at least 150 kinds of natural saponins have been found to possess significant anti-cancer properties.

Ginsenosides from ginseng have shown anticancer activity against lung, colon, and liver cancers in preclinical studies. Several pre-clinical and clinical studies have demonstrated the anticancer potential of Panax ginseng, a widely used traditional Chinese medicine. The anti-tumor efficacy of ginseng is attributed mainly to the presence of saponins, known as ginsenosides.

Ginsenoside Rg3 induces immunogenic tumor cell death with induction of cytokine interferon-γ (IFN-γ) secretion and reduction of inflammatory cytokines IL-6, TNF-α, and TNF-β1, as well as enhances uptake of tumor cells by dendritic cells, indicating that ginsenoside Rg3 may be an effective immunotherapeutic agent.

Astragaloside has been found to inhibit proliferation and induce apoptosis in breast cancer cells, exhibiting varied effects across different cell types.

Evidence strength: Preliminary to moderate. The preponderance of anticancer evidence derives from in vitro cell studies and animal models. TCM, as an ancient science with unique anti-cancer advantages, has achieved outstanding results in long-term clinical practice, but rigorous randomized controlled trials for isolated saponins as primary anticancer agents in humans remain sparse. Most human data exist for ginseng extracts (not isolated ginsenosides), with heterogeneous study populations and outcomes.

7.4 Anti-inflammatory Activity

Steroidal saponins exhibit diverse pharmacological ability including antimicrobic, anti-inflammatory, cAMP phosphodiesterase inhibitory, antiadipogenic, bactericide, cardioprotective, antitumor, antidiabetic, cytotoxic activity, antifungal, antiviral, antioxidant, and hepatoprotective properties.

Increasing evidence highlights the ability of plant-derived saponins, including ginsenosides and astragalosides, to regulate macrophage polarization, making them promising candidates for immune modulation. Specifically, ginsenoside Rg1 upregulates anti-inflammatory M2 markers — like CD11b+F4/80+Arg1+ and CD206+ — enhancing their polarization and increasing IL-4 and IL-10 expression. These findings are largely from in vitro and animal studies.

Evidence strength: Mostly preclinical. Anti-inflammatory effects of saponins are well established in cell culture and animal models. Human clinical evidence is limited to a small number of trials, predominantly on multi-ingredient herbal extracts rather than isolated saponins.

7.5 Antidiabetic and Metabolic Effects

Activities of triterpenoid saponins encompass a spectrum from antibacterial and anti-inflammatory/antioxidant to blood pressure modulation, antidiabetic, antipyretic, sedative, and anticancer properties.

Inhibitory activities of saponins on digestive enzymes such as lipase, amylase, and glucosidase enzymes are of recent relevance because any limited digestion of dietary macronutrients such as lipids or carbohydrates is currently considered a relevant strategy against important chronic diseases such as obesity, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, or diabetes.

Evidence strength: Mostly preclinical. Mechanistic enzyme-inhibition studies are well-supported in vitro. Clinical evidence for glycemic control specifically from saponin supplementation in humans is preliminary.

7.6 Neuroprotective Effects

Ginsenosides have been noted for their role in reducing nerve damage leading to neurological disorders, including Alzheimer's disease, Parkinson's disease, depression, cognitive impairment, and cerebral ischemia, in addition to their therapeutic impacts on cardiovascular and cerebrovascular diseases and cancer.

Saponins such as Shubashin D exhibit neuroprotective effects against Aβ25-35-induced cytotoxicity in PC12 cells, suggesting potential therapeutic applications against Alzheimer's disease. This is an in vitro finding in neuronal cell models.

Evidence strength: Preliminary (mostly animal and cell-based). Human clinical trials in neurological contexts are lacking for isolated saponins.

7.7 Intestinal Health and Gut Microbiota

Together with the role of the microbiota on the final bioactivity of dietary saponins, it is also important to remark the impact of saponins on the microbiota itself and the derived consequences. The current information about the relationship between saponins, microbiota and health is scarce, but promising, because recent research has pointed to saponins as "prebiotic-like" compounds, similarly to polyphenols.

A recent small human pilot study illustrated saponins' potential effect on gut and muscle health: a randomized, double-blind, placebo-controlled crossover trial was conducted with 30 healthy participants over two phases — a single-dose trial and a 4-week phase. Immediate supplementation with Astragalus and Panax saponins resulted in a 6.67% higher area under the curve for valine and 3.62% for leucine compared with placebo. After 4 weeks, the supplementation significantly increased the absorption of valine (14.07%) and leucine (8.34%). APS also caused a substantially greater increase in grip strength, an increase in muscle mass, and a reduction in blood zonulin levels, indicating improved muscle function and intestinal barrier integrity, without adverse effects on liver or kidney function. This was a small-scale pilot study and requires replication in larger trials.

7.8 Antimicrobial Activity

Saponins are detergent-like substances showing antibacterial as well as anticancer potential. In one study, the effects of saponins from Quillaja saponaria were analyzed against prokaryotic and eukaryotic cells. Saponin from Quillaja saponaria has a cytotoxic effect at concentrations higher than 25 μg/mL and in the range of 12–50 μg/mL significantly increases the level of early apoptotic cells.

Evidence strength: Mostly in vitro. Antimicrobial effects of saponins are well documented in laboratory settings. Human clinical evidence for saponins as primary antimicrobial agents is not available.

8. Bioavailability and Pharmacokinetics

Saponins are generally regarded as having low bioavailability. The absorption of saponins in the human diet is highly variable and is affected by several factors, including the amount of saponins consumed in a meal, interaction of saponins with bile acids and other micronutrients, food processing methods, and metabolic adaptation of individuals to dietary saponins.

Poor intestinal absorption of saponins is mainly due to their unfavorable physicochemical traits, such as large molecular mass (>500 Da), high hydrogen-bonding capacity (>12), and high molecular flexibility (>10), that underlie poor membrane permeability. Rapid and extensive biliary excretion is another primary factor that limits the oral bioavailability of most saponins.

The oral bioavailability of ginsenosides Ra3, Rb1, and Rd was found to be 0.1–0.2%, whereas ginsenosides Re, Rg1, and notoginsenoside R1 showed 0.2–0.6%. These extremely low oral bioavailability figures are a key limiting factor in translating preclinical findings to human outcomes.

The colonic transformation of saponins allows the release of sapogenins (aglycones), thereby influencing their bioavailability to be lower or higher when compared to the precursor saponin. Saponins can be hydrolyzed by the colonic microflora. After absorption, the deglycosylated aglycones undergo phase I and/or II metabolism by the host.

The clinical application of saponins is limited by their low bioavailability and short half-life, resulting in fluctuating plasma concentrations. Future directions should focus on novel saponin compounds utilizing colon-specific delivery and osmotic pump systems to enhance oral bioavailability.

The intestinal absorption ratios of notoginsenoside R1, ginsenoside Rb1, ginsenoside Rd1, and total saponins from San-Chi (a traditional herb) were 86.57, 18.56, 73.30, and 40.20%, respectively, in a biomimetic model. The oral bioavailability of saponins was controlled by saponin species, gastrointestinal digestion, and edible plant combination.

9. Safety Considerations

9.1 Hemolytic Activity

Saponins are a type of compound bearing a hydrophobic steroid/triterpenoid moiety and hydrophilic carbohydrate branches. The majority of the saponins demonstrate a broad range of prominent pharmacological activities. Nevertheless, many saponins also possess harmful hemolytic toxicity, which can cause the lysis of erythrocytes and thereby hamper their applications in medicine.

Saponins are hemolytic and can form complexes with sterols of the erythrocyte membrane, causing the rupture of the erythrocyte, resulting in an increase in permeability, hemoglobin loss, and hemolysis; the hemolytic activity is highly correlated with its structure (sugar chains and glycosides). Not all saponins are hemolytic; for example, ginsenosides are not hemolytic, but after isolation, b-type and c-type ginsenosides are significantly hemolytic, whereas a-type saponins are anti-hemolytic.

Critically, hemolysis is a concern primarily for parenteral (injectable) administration. Dietary saponins are poorly absorbed, thus suggesting their cholesterol-lowering action occurs in the intestine, and by extension, orally consumed saponins at normal dietary levels do not typically reach systemic concentrations sufficient to cause hemolysis in healthy individuals. However, intravenous use presents a significant risk.

9.2 Hepatotoxicity and Organotoxicity

Saikosaponin A and D have been shown to cause mitochondrial apoptosis in hepatocytes leading to hepatotoxicity and liver damage. Both in vitro and in vivo studies showed that the spirostanol saponin terrestrosin D had potential hepatorenal toxicity. Excessive use of saponins can also cause damage to metabolic organs such as the liver and kidneys.

9.3 Gastrointestinal Effects

The uptake of the extracellular space marker polyethylene glycol 4000 was higher in the presence of certain saponins, indicating that the saponin inhibited active transport by increasing the general permeability of the enterocytes. Some saponins readily increase the permeability of the small intestinal mucosal cells, thereby inhibiting active nutrient transport, and facilitating the uptake of materials to which the gut would normally be impermeable. This finding — derived from in vitro intestinal preparations — suggests that high-dose saponin exposure could theoretically facilitate absorption of compounds (including toxins or undigested proteins) that would normally be excluded. Dietary concentrations from food sources are unlikely to produce this effect.

9.4 Ichthyotoxicity and Ecological Concerns

Since prehistoric times, cultures throughout the world have used fish-killing plants, typically containing saponins, for fishing, indicating that at sufficient concentrations, saponins are toxic to aquatic vertebrates. This underlies their ecological function as chemical defenses.

9.5 Structure-Dependent Toxicity

Other studies have suggested the hemolytic properties of saponins could be due to several factors including the types of side chains and the number of appended glycosides and polar functional groups present in the aglycone. This means that toxicity profiles are highly compound-specific and cannot be generalized across the entire saponin class. The toxicity of Quil A (the crude saponin extract) versus QS-21 (the purified fraction) illustrates this: more than 30 years ago, semi-purified extracts (Quil A) from the cortex of Quillaja saponaria were found to be highly effective as adjuvants in veterinary vaccines. However, due to significant and variable toxicity effects, Quil A was not deemed appropriate for human vaccines.

9.6 Antinutritional Properties

Many Medicago plant species are toxic for herbivores due to their higher saponins quantity, and Medicago saponins are reported to be toxic for birds and animals. In human food contexts, saponin concentrations in commonly consumed foods (legumes, quinoa, spinach) are generally considered low enough to be safe, particularly after standard cooking and processing such as soaking, rinsing, and heating.

10. Body Systems and Health Areas Associated with Saponins

Saponins, from a variety of sources, have been shown to have hypocholesterolemic, anti-coagulant, anticarcinogenic, hepatoprotective, hypoglycemic, immunomodulatory, neuroprotective, anti-inflammatory, and anti-oxidant activity. This breadth encompasses:

• Cardiovascular system: Lipid modulation, cholesterol absorption inhibition, potential antithrombotic effects
• Immune system: Adjuvancy (QS-21 in licensed vaccines), macrophage polarization, T-cell activation
• Digestive system: Bile acid binding, cholesterol precipitation, enzyme inhibition, gut microbiota modulation
• Metabolic system: Antidiabetic enzyme inhibition, AMPK pathway activation, antiobesity effects
• Nervous system: Neuroprotective effects (ginsenosides, preclinical)
• Oncology: Antiproliferative, pro-apoptotic, anti-angiogenic, and MDR-reversing activities (preclinical and early clinical)
• Hepatic system: Hepatoprotective effects at appropriate doses; hepatotoxic potential at excess doses with certain saponins
• Musculoskeletal system: Diosgenin has the potential of preventing neurological diseases by affecting different signaling pathways, increasing bone formation, and increasing antithrombotic activity.

11. Dosage Forms and Reported Dosages

Saponins are available in the following dosage forms in research and clinical/supplement contexts:

• Oral tablets, capsules, and powders: The most common form for dietary supplementation of saponin-containing plants
• Liquid extracts and decoctions: Traditional preparation form for TCM plants such as ginseng and licorice
• Standardized extracts: Fractions standardized to a defined percentage of total saponins or a specific saponin (e.g., ginsenoside content)
• Injectable formulations: Used in pharmaceutical contexts (e.g., escin for intravenous use in some European countries, QS-21 as a vaccine component)

Specific dosages reported in research:

• Escin (aescin): Evaluated in a clinical trial as either an oral formulation (40 mg three times a day) or injection (20 mg intravenously once a day) for 12 days.
• Astragalus and Panax saponins (APS): Studied over two phases: a single-dose trial measuring immediate amino acid absorption from whey protein, and a 4-week phase combining daily supplementation with resistance training in 30 healthy participants; specific dose amounts were not fully detailed in the publicly available abstract.
• Gynosaponins: Effects of the saponin component can be obtained if an adult uses it in the amount of 20 to 500 mg, preferably 50 to 300 mg, per day, taken in two or three installments every day.

The available information about digestion, bioaccessibility, and bioavailability of saponins or sapogenins is still scarce due to the wide chemical diversity and complexity of saponins, so it cannot be generalized that all saponins or sapogenins have a low bioavailability, and this is likely the reason why most studies demand higher research in order to be able to establish the safe and effective oral doses.

12. Current Research Landscape and Outstanding Questions

Recent research on traditional Chinese medicine (TCM) saponin pharmacokinetics has revealed transformative breakthroughs and challenges. The multicomponent nature of TCM makes it difficult to select representative indicators for pharmacokinetic studies. The clinical application of saponins is limited by their low bioavailability and short half-life, resulting in fluctuating plasma concentrations.

Future directions should focus on novel saponin compounds utilizing colon-specific delivery and osmotic pump systems to enhance oral bioavailability. Optimizing drug combinations, such as ginsenosides with aspirin, shows therapeutic potential. Rigorous clinical validation is essential for practical applications.

Some saponins have revealed good biological and pharmacological properties, such as antimicrobial, antidiabetic, and anticancer. Given the previously reported results, saponins are a real opportunity for the pharmaceutical, industrial and extra-pharmaceutical fields.

The overall state of evidence can be summarized thus: saponins as a class possess mechanistically plausible and preclinically well-supported biological activities across multiple organ systems. Although saponins are considered beneficial in several medical conditions and are being used as alternative medical substances, a detailed understanding of the relationship between the chemistry of saponins and their interactions with signaling and other pathways remains incomplete. The exception is the use of QS-21 in licensed vaccines, which represents a mature, clinically validated application. For most other areas — cholesterol lowering, antidiabetic effects, neuroprotection, and cancer — the evidence base consists predominantly of animal models, in vitro experiments, and small uncontrolled human studies, and further rigorously designed randomized controlled trials are required.

References

• Vincken J-P et al. (2007). Saponins, classification and occurrence in the plant kingdom. Phytochemistry. PubMed.
• Oakenfull D, Sidhu GS. (2001). The bioactivity of saponins: triterpenoid and steroidal glycosides. Critical Reviews in Food Science and Nutrition. PubMed.
• Augustin JM et al. (2011). Metabolic and functional diversity of saponins, biosynthetic intermediates and semi-synthetic derivatives. Phytochemistry. PMC.
• Bkhaitan MM et al. (2021). Biological Activities and Chemistry of Triterpene Saponins from Medicago Species: An Update Review. PMC.
• Guo J et al. (2020). Review of Constituents and Biological Activities of Triterpene Saponins from Glycyrrhizae Radix et Rhizoma. PMC.
• Xu M, Wan Z, Yang X. (2021). Recent Advances and Applications of Plant-Based Bioactive Saponins in Colloidal Multiphase Food Systems. PMC.
• Man S et al. (2010). Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia. PubMed.
• Güçlü G et al. (2023). Perspectives on Saponins: Food Functionality and Applications. PMC.
• He W et al. (2014). The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats. PMC.
• Otaegui-Arrazola A et al. (2017). Food Ingredients That Inhibit Cholesterol Absorption. PMC.
• Vinarova L et al. (2015). Lowering of cholesterol bioaccessibility and serum concentrations by saponins: in vitro and in vivo studies. PubMed.
• Zhang Y et al. (2024). Effects of Saponins on Lipid Metabolism: The Gut–Liver Axis Plays a Key Role. PMC.
• Kensil CR, Kammer R. (2013). Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. PMC.
• Lacaille-Dubois MA, Wagner H. (2020). Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review. PMC.
• Welsby I et al. (2016). Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21. PMC.
• Marciani DJ. (2014). Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant. PMC.
• Gu Q et al. (2025). Advancements in saponin-based vaccine adjuvants. Medicinal Chemistry Research. Springer.
• Gao Y et al. (2025). From bark to bench: innovations in QS-21 adjuvant characterization and manufacturing. PMC.
• Wan D et al. (2019). Chemical Structures and Pharmacological Profiles of Ginseng Saponins. PMC.
• Hassan HM et al. (2022). Saponins in Cancer Treatment: Current Progress and Future Prospects. PMC.
• Nag SA et al. (2012). Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action. PMC.
• Cheng Z et al. (2018). Saponins from Chinese Medicines as Anticancer Agents. PMC.
• Zhu M et al. (2023). Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review. PMC.
• Li X et al. (2025). Natural saponins and macrophage polarization: Mechanistic insights and therapeutic perspectives in disease management. PMC.
• Ma Y et al. (2024). Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review. PMC.
• Srivastava S et al. (2018). Structural characteristics, bioavailability and cardioprotective potential of saponins. PMC.
• Wen L et al. (2023). Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era. PMC.
• Johnson IT et al. (1986). Influence of saponins on gut permeability and active nutrient transport in vitro. PubMed.
• Liu Z et al. (2019). Prediction of Hemolytic Toxicity for Saponins by Machine-Learning Methods. PubMed.
• Lin L et al. (2013). Influence of gastrointestinal digestion and edible plant combination on oral bioavailability of triterpene saponins. PubMed.
• Pérez-Jiménez J et al. (2018). The gastrointestinal behavior of saponins and its significance for their bioavailability and bioactivities. Journal of Functional Foods. ScienceDirect.
• Gao H, Kuroyanagi M, Wu LJ et al. Absorption, Disposition, and Pharmacokinetics of Saponins from Chinese Medicinal Herbs. Bentham Science.
• Lim HH et al. (2025). Effects of Astragalus membranaceus and Panax notoginseng Saponins Extract on Pharmacokinetics of Whey Protein Absorption, Intestinal Permeability, and Muscle Function: A Pilot Study. PMC.
• Sureshkumar et al. (2022). Plants' Steroidal Saponins — A Review on Its Pharmacology. World Journal of Traditional Chinese Medicine.
• Saponin. Wikipedia (for nomenclature/etymology cross-reference only).